Examine the emerging evidence on new non-hormonal therapies (i.e. neurokinin-3 (NK3) receptor antagonists) for the treatment of vasomotor symptoms.
Discuss the role of menopause hormone therapy in managing symptoms during the menopause transition, including treatment expectations and strategies for addressing potential side effects such as uterine bleeding.